We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$155B
AUM Growth
+$5.59B
Cap. Flow
-$1.23B
Cap. Flow %
-0.8%
Top 10 Hldgs %
15.41%
Holding
3,924
New
119
Increased
2,245
Reduced
1,145
Closed
87

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$128M
2
AAL icon
American Airlines Group
AAL
+$99.2M
3
NAVI icon
Navient
NAVI
+$54.9M
4
ESS icon
Essex Property Trust
ESS
+$53.7M
5
AVGO icon
Broadcom
AVGO
+$47.2M

Sector Composition

Rank Sector Weight
1 Financials 14.61%
2 Technology 13.94%
3 Healthcare 13.29%
4 Industrials 10.85%
5 Energy 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FEIM icon
3501
Frequency Electronics
FEIM
$816M
$175K ﹤0.01%
14,272
GV
3502
DELISTED
Goldfield Corporation
GV
$175K ﹤0.01%
101,746
KBIO
3503
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$174K ﹤0.01%
9,545
-814
-8% -$13.9K
EGRX
3504
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$173K ﹤0.01%
12,101
-1,669
-12% -$19K
RHE
3505
DELISTED
Regional Health Properties, Inc.
RHE
$173K ﹤0.01%
3,380
+2,471
+272% +$121K
NWG icon
3506
NatWest
NWG
$76.4B
$172K ﹤0.01%
14,215
+2,477
+21% +$29.1K
NJ
3507
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$172K ﹤0.01%
+11,179
New +$163K
FU
3508
DELISTED
FAB UNIVERSAL CORP COM
FU
$171K ﹤0.01%
55,930
AWRE icon
3509
Aware
AWRE
$27.7M
$170K ﹤0.01%
25,967
IMNN icon
3510
Imunon
IMNN
$6.77M
$170K ﹤0.01%
18
DMK
3511
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$170K ﹤0.01%
508
+207
+69% +$81.3K
SMED
3512
DELISTED
Sharps Compliance Corp
SMED
$170K ﹤0.01%
38,753
-59
-0.2% -$244
STKL
3513
DELISTED
SunOpta
STKL
$168K ﹤0.01%
11,946
-176
-1% -$2.19K
PIOI
3514
DELISTED
Active Power Inc
PIOI
$168K ﹤0.01%
61,151
-61
-0.1% -$174
ARGS
3515
DELISTED
Argos Therapeutics, Inc.
ARGS
$166K ﹤0.01%
1,039
-143
-12% -$23.6K
DSGX icon
3516
Descartes Systems
DSGX
$6.82B
$165K ﹤0.01%
11,543
-173
-1% -$2.35K
ENG
3517
DELISTED
ENGlobal Corp
ENG
$165K ﹤0.01%
6,617
-9
-0.1% -$193
ASTC icon
3518
Astrotech Corp
ASTC
$17.8M
$164K ﹤0.01%
345
GROW icon
3519
US Global Investors
GROW
$38.5M
$164K ﹤0.01%
46,643
-71
-0.2% -$245
PPIH
3520
Perma-Pipe International
PPIH
$215M
$164K ﹤0.01%
14,425
ADGE
3521
DELISTED
American Dg Energy Inc
ADGE
$164K ﹤0.01%
91,665
PULB
3522
DELISTED
PULASKI FINANCIAL CORP
PULB
$163K ﹤0.01%
14,355
-42
-0.3% -$455
SMSI icon
3523
Smith Micro Software
SMSI
$16.2M
$162K ﹤0.01%
979
-1
-0.1% -$198
KSPN
3524
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$162K ﹤0.01%
2,135
-206
-9% -$14.1K
LOCM
3525
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$162K ﹤0.01%
78,225

Similar funds

Geode Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Geode Capital Management held 3,924 positions worth $155B, up 3.7% from $149B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management's Q2 2014 filing shows 119 new, 2,245 increased, 1,145 reduced and 87 closed positions. Its largest new stake was Navient: 3,319,977 shares worth $58.8M. The largest sale was Apple, an estimated $219M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Geode Capital Management's largest Q2 2014 buy was Navient: 3,319,977 shares worth $58.8M.
  • Geode Capital Management added most to Allergan plc in Q2 2014, an estimated $128M increase.
  • Geode Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $219M.
  • Geode Capital Management fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $103M.
  • Geode Capital Management's ten largest holdings make up 15% of its $155B portfolio in Q2 2014.
  • Geode Capital Management opened 119 new positions and closed 87 in Q2 2014.
  • Geode Capital Management's portfolio value rose 3.7% quarter-over-quarter to $155B.

Based on Geode Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.